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BACKGROUND: The aim of the present study was to evaluate the prognostic significance of peri-
neural invasion (PNI) in locally advanced gastric cancer patients who underwent D2 gastrectomy
and adjuvant chemotherapy.
METHODS: The records of a series of 103 patients undergoing D2 gastrectomy with curative intent
combined with adjuvant chemotherapy from January 2004 to December 2014 were retrospectively
reviewed.
RESULTS: PNI was positive in 47 (45.6%) specimens. The 1-, 3-, and 5-year overall survival rates
were 81%, 55%, and 42%, respectively. The 1-, 3-, and 5-year disease-free survival (DFS) rates were
76%, 57%, and 49%, respectively. A multivariate analysis showed that age number of positive lymph
nodes, T stage, and PNI were independently associated with overall survival. Regarding DFS, the multi-
variate analysis showed that only PNI was independently associated with DFS.
CONCLUSIONS: PNI and T stage and positive lymph nodes are independent markers of poor prog-
nosis in patients with gastric cancer. PNI should be incorporated in the postoperative staging system for
planning follow-up after surgery and in our opinion to propose more aggressive postoperative therapies
in PNI-positive patients.
 2016 Elsevier Inc. All rights reserved.Gastric cancer is the fourth most common malignancy
and the second most common cause of cancer-related deathnterest.
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16.05.022worldwide.1 Tumor stage, tumor size, grade of differentia-
tion, and lymph node metastasis are well-established prog-
nostic factors and lymphovascular invasion (LVI), which is
also known to be an independent factor for lymph node
metastasis and for survival.2 The prognostic value of
LVI, in fact, has been investigated by many authors, con-
firming the importance of this histopathologic parameter
on patient’s outcome.2,3
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carcinomatous spread or perineural spread, is the process
through which cancer cells invade perinerium and neural
fascicles. This is an important pathway for local spread of
cancers and is also related to cancerous pain, cancer
recurrence, and poor prognosis.
Up to now, the understanding of PNI pathogenesis is still
in its infancy. However, this is recognized to be associated
with a more aggressive tumor and with a poorer prognosis
in several malignancies, such as head and neck tumors and
prostate cancer.4–8 Regarding gastric cancer, PNI’s prog-
nostic value has not reached any general consensus, and
the role of its positivity on predicting outcomes after cura-
tive gastric resection for cancer is still under debate. Bilici
et al9 found that the median survival of PNI-positive pa-
tients was worse than those having PNI-negative cancers
and demonstrated that this is a useful prognostic factor
for curative gastric cancer surgery. However, in the study
presented by Duraker et al10 in 2003, although the positiv-
ity of PNI was 59.6% among patients, this did not provide
any additional prognostic information to the well-
established oncologic parameters. Other studies further-
more analyzed the usefulness of PNI in predicting
outcomes of patients with gastric cancer, describing no
association with survival.11–14
Because of the lack of consensus, in this article, we
evaluated the prognostic significance of PNI in locally
advanced gastric cancer patients who underwent curative
D2 gastrectomy and adjuvant chemotherapy.Patients and Methods
The records of a series of 126 consecutive patients who
underwent resection for gastric cancer from January 2004
to December 2014, at S. Andrea Hospital, La Sapienza,
University of Rome, were retrospectively reviewed. All
patients had undergone gastrectomy and modified D2
lymphadenectomy with curative intent according to tumor
location and extent of disease. Only patients who under-
went curative-intent surgery were included.
Combined resection of other organs, such as the spleen,
pancreas, and colon, was performed in case of direct
invasion. Patients with residual disease either microscopi-
cally (R1) or macroscopically (R2) were excluded from the
study. None of the patients included in the study had liver
or distant metastases at time of surgery.
No patients underwent neoadjuvant chemotherapy, and
all the patients were treated with adjuvant chemotherapy
(oxaliplatin and capecitabine) after surgery as proposed in
the ‘‘Associazione Italiana di Oncologia Medica’’ guide-
lines (www.aiom.it). Standard clinicopathologic data were
collected, including age, sex, operation type, tumor size, tu-
mor location, type of procedure, histologic type and grade
of the tumor, depth of invasion, number of lymph nodes
harvested, number of metastatic lymph nodes, lymph
node ratio (LNR), LVI and PNI, and final American JointCommittee on Cancer pathologic stage of disease. T stage
and nodal status were determined using the American Joint
committee on Cancer Staging Manual, Seventh Edition.15
The LNR was calculated based on the relationship between
positive nodes and total nodes of the specimen.16
For histologic parameters, multiple samples were ob-
tained from every surgical specimen, 4-mm-thick sections
of each formalin-fixed paraffin-embedded tissue block were
cut and hematoxylin and eosin stained. Each slide was
carefully and separately reviewed by 2 of the authors
(G.L.R.V. and F.S.) in blind. Doubtful cases were further
discussed together to reach concordance.
LVI was considered positive when either single tumor
cells or cell clusters were clearly visible within an
endothelium-lined vessel-like structure. PNI was defined
as the presence of cancer cells along nerves and/or within
the epineurial, perineurial, and endoneurial spaces of the
neuronal sheath including cases in which the cell circum-
scribed at least 33% of the nerves.17
Data of last follow-up or death, recurrence-related
information, such as site of recurrence and treatment, and
vital status were also collected. Patients who died within
30 days of surgery and also those who lost to follow-up
were excluded. Ultimately, 103 patients were eligible. The
last follow-up was dated on June 2015. Clinicopathologic
characteristics of the 103 patients are listed in Table 1.
Statistical analysis
Overall survival (OS) was defined as the interval
between the date of operation and the date of death for
any cause or last patient visit. Disease-free survival (DFS)
was defined as the time from operation until tumor relapse
either local or distant. Comparison of categorical variables
was performed using the chi-square test. Kaplan–Meier
curves were generated for OS and DFS, and differences in
survival rates between groups were compared by the log-
rank test. A backward stepwise Cox regression model was
used to identify variables influencing OS and DFS.
Multivariate analysis was performed using those variables
that have significant independent relationship with OS and
DFS. Significance was defined as a P value ,.05. All sta-
tistical analyses were performed using the SPSS for Mac,
version 17.0 (SPSS, Inc., Chicago, IL).
Results
Thirty-three (32%) patients presented with gastrointes-
tinal bleeding, 15 (14.5%) with obstruction, and 55 (53.3%)
complaining of pain and discomfort. Lymph node invasion
was suspected in 63 (61.1%) patients at radiologic evalu-
ation before surgery.
A total gastrectomy was performed in 57 (55.3%)
patients, 46 (44.6%) underwent a subtotal distal gastrec-
tomy, whereas 16 (15.5%) received a combined procedure
because of direct tumor invasion; more in detail,
Table 1 Patient’s perioperative characteristics
Variables N 5 103
Sex (F/M) 48/55
Age . 70 y 57 (55%)
Mean 70.2 6 11
ASA score (I/II/III) 22/31/50
Tumor site
Antrum/pyloric 47 (46%)
Proximal/upper third 24 (23%)
Body/middle third 30 (29%)
Gastric stump* 2 (2%)
Type of operation
Total gastrectomy 57 (55%)
Distal subtotal gastrectomy 46 (45%)
Combined procedures 16/103 (15%)
Tumor size (mm) 15 6 18
No. of lymph nodes retrieved 28.7 6 14
No. of metastatic lymph nodes 7.2 6 11
Lymph node ratio .2 6 .2
Lauren type
Diffuse type 29 (28%)
Intestinal type 68 (66%)
Mixed type 6 (6%)
Depth of invasion
T1 19 (18%)
T2 34 (33%)
T3 29 (28%)
T4 21 (20%)
Node status
N0 38 (37%)
N1 24 (23%)
N2 13 (13%)
N3 28 (27%)
Stage Ib/II/III 22/25/56
Grading (G1/G2/G3/G4) 8/20/69/8
LVI 78 (78%)
PNI 47 (46%)
ASA 5 American Society of Anesthesiology; F 5 female; LVI 5
lymphovascular invasion; M 5 male; PNI 5 perineural invasion.
*After previous subtotal gastrectomy.
Figure 1 (A) Patient’s OS curve. (B) Patient’s DFS curve.
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(2.9%) underwent a right hemicolectomy, 1 (.9%) a jejunal
loop resection, and 1 (.9%) patient underwent a pancrea-
ticoduodenectomy because of direct tumor invasion. After
pathologic examination, mean tumor diameter was 15 6
18.4 mm; all resections were R0 on all margins. PNI was
positive in 47 (45.6%) specimens, whereas LVI was present
in 78 (75.7%).
The median duration of follow-up was 26 months (2 to
138 months). Of 103 patients, 57 patients (55.3%) had died
and 46 (44.6%) patients were alive at the end of follow-up.
Forty-two patients (73.6%) of the study died from cancer-
related causes. The 1-, 3-, and 5-year OS rates were 81%,
55%, and 42%, respectively. After R0 resection, 45 patients
(44%) developed a recurrence that was locoregional in most
of the cases (56%). The 1-, 3-, and 5-year DFS rates were
76%, 57%, and 49%, respectively. Survival curves areshown in Fig. 1A,B. At a subgroup analysis, patients with
positive PNI had a significantly worse 5-year actuarial OS
(59% vs 19%, P 5 .0001; Fig. 2A) and DFS compared
with patients without PNI (69% vs 22%, P 5 .0001;
Fig. 2B).
The univariate analysis showed that age (P 5 .003),
number of positive lymph nodes (P 5 .0001), LNR (P 5
.0001), tumor stage (P 5 .005), LVI (P 5 .007), and PNI
(P 5 .0001) were associated with OS. A multivariate anal-
ysis of these significant variables showed that age (P 5
.001), number of positive lymph nodes (P 5 .03), T stage
(P 5 .04), and PNI (P 5 .004) were independently associ-
ated with OS (Table 2).
Figure 2 (A) Patient’s OS according to perineural invasion. (B)
Patient’s DFS according to perineural invasion.
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number of positive lymph nodes (P 5 .0001), LNR (P 5
.0001), tumor stage (P 5 .02), PNI (P 5 .0001), and LVI
(P5 .002) were significant. A multivariate analysis of these
significant variables showed that only PNI (P 5 .01) was
independently associated with DFS (Table 3).Comments
The incidence of PNI has been already documented in
previous studies, ranging from 6.8% to 75.6% in oncologic
patients and approximately 20% in colonic and rectal
carcinoma.18 This incidence is described as much higher
in pancreatic carcinoma (50% to 80%) and in carcinomaof the biliary tract (85% to 88%).19–23 No clear association
between PNI and metastases has been evidenced in all these
studies concerning different type of cancers.
The exact molecular mechanism mediating the interac-
tion between cancer and neural cells during PNI is poorly
understood. Xia et al24 using an in vitro tumor–neural cell
culture system demonstrated that gastric cancer cells not
only promote neural progenitor cells’ proliferation but
also can enhance neurite elongation and branching of post-
mitotic neural cells. Such morphologic changes contribute
to the observation that neural cells can facilitate migration
and invasion of cancer cells toward neuronal axons.
Furthermore, PNI is described as being related to the close
anatomical association between the tumor and the neural
plexus and on the special ability of cancer cells to easily
recognize neural tissue by secreting neural cell adhesion
molecule.25,26
Deng et al27 in their systematic review and meta-
analysis demonstrated the prognostic role of PNI in gastric
cancer patients, showing that this is independent from
lymph nodes status, tumor size, and tumor grade and a
range of other biologic variables on multivariate analysis.
Despite this, only few of the included studies reported out-
comes specifically concerning PNI, analyzing patients with
positive or negative PNI by subgroups. Furthermore, het-
erogeneity between studies was described for both OS
and DFS analysis when pooling results and only 4 articles
could be included in the analysis concerning DFS.
Jiang et al28 in a group of patients who underwent
radical resection for gastric carcinoma found that the pres-
ence on PNI had a significant correlation with size of tumor
(R5 cm), lymphatic venous invasion, deeper tumor inva-
sion (T4), lymph node metastases (N3), and deeper TNM
stage (III), which were proved to be associated with worse
survival outcomes. In the multivariate analysis, presence of
PNI and classical oncologic variables maintained signifi-
cance and was recognized as an independent prognostic
factor in gastric carcinoma patients with poor survival.
On the other hand, Duraker et al found that although PNI
was positive in 211 of the 354 patients (59.6%) with gastric
carcinoma and the incidence of PNI increased with disease
stage, this variable did not provide any additional informa-
tion to the classical and well-established oncologic prog-
nostic parameters; this was subsequently confirmed in other
studies worldwide.10–14
In the present article, we investigated incidence and
prognostic value of PNI in a group of patients who
underwent potentially curative resection for gastric carci-
noma. The incidence of PNI detected by histopathology
analysis of surgical specimens was 45.6%.
Survival curves of our case series revealed a reasonable
5-year actuarial OS and DFS for gastric cancer patients, in
accordance with the literature. Furthermore, the long-term
follow-up although of a relatively limited case series
improves the statistical value of the curves. Confirmation
from future studies could strengthen our results. What is
interesting is that at a subgroup analysis, patients with PNI
Table 2 Predictive factors for overall survival
Variables
Univariate analysis Multivariate analysis
OR (95% CI) P value OR (95% CI) P value
Female sex .84 (.50–1.42) .52
Age 1.04 (1.01–1.07) .003 1.05 (1.01–1.08) .001
Tumore size (mm) 1.00 (.99–1.01) .40
N lymph nodes retrieved 1.00 (.98–1.02) .44
N positive lymph nodes 1.03 (1.02–1.05) .001 1.03 (1.00–1.07) .03
LNR 5.64 (2.42–13.14) .001 .61 (.11–3.35) .57
T stage
I 1 .005 1 .04
II 2.84 (1.06–7.61) .03 2.19 (.68–7.02) .18
III 5.55 (2.02–15.22) .001 5.08 (1.44–17.91) .01
IV 5.05 (1.73–14.72) .003 3.74 (1.03–13.54) .04
TNM stage III 2.02 (.63–4.16) .34
Diffuse histology 1.08 (.60–1.96) .78
Poor differentiation (G4) 1.41 (.81–2.60) .21
Lymphovascular invasion 2.70 (1.31–5.54) .007 1.08 (.42–2.75) .86
Perineural invasion 3.07 (1.77–5.30) .0001 2.44 (1.34–4.45) .004
CI 5 confidence interval; LNR 5 lymph node ratio; OR 5 odds ratio; TNM 5 tumor-node-metastasis.
752 The American Journal of Surgery, Vol 213, No 4, April 2017had a significantly worse OS and DFS, suggesting the role
of neural cancer cell invasion in survival. These data were
furthermore confirmed in the Cox regression analysis in
which PNI was recognized to be an independent factor
predicting oncologic outcomes.
Other well-known oncologic variables, such as positive
lymph nodes and T stage, resulted significantly associated
with OS at multivariate analysis. These 2 important
prognostic factors are currently used for stratifying patients
to decide the best treatment strategy. Jiang et al28 incorpo-
rated PNI into N3 and TNM stage III in patients with
gastric carcinoma through the redefinition of stage III in
IIIPNI and N stage in NPNI. Their under-categorizationTable 3 Predictive factors for disease-free survival
Variables
Univariate analysis
OR (95% CI)
Female sex .85 (.63–1.14)
Age 1.01 (.98–1.04)
Tumor size (mm) 1.00 (.99–1.02)
N lymph nodes retrieved 1.01 (.99–1.03)
N positive lymph nodes 1.04 (1.02–1.06)
LNR 9.32 (3.55–24.51)
T stage
I 1
II 14.76 (1.97–110.13)
III 20.17 (2.66–152.84)
IV 11.21 (1.37–91.83)
TNM stage III 1.64 (.25–4.33)
Diffuse histology 1.13 (.68–1.89)
Poor differentiation (G4) 12.72 (.68–20.33)
Lymphovascular invasion 5.04 (1.79–14.14)
Perineural invasion 3.86 (2.05–7.29)
CI 5 confidence interval; LNR 5 lymph node ratio; OR 5 odds ratio; TNMreached a lower 22 log-likelihood value and a higher haz-
ard ratio and 95% confidence interval, which represented an
optimum prognostic stratification, together with better ho-
mogeneity, and discriminatory ability. We believe that the
results of our study could confirm the usefulness of this
incorporation because of the link between PNI and survival.
Most gastric cancer patients, even after curative resec-
tion, experienced recurrence with a rate of 60% and median
length of survival after recurrence of 7.4 months in case of
distant metastases and 10.4 months in case of local
recurrence.29 In this context, considering the results of
the present study in which PNI turned to be statistically
and independently associated with DFS, this, in our opinionMultivariate analysis
P value OR (95% CI) P value
.29
.32
.45
.26
.0001 1.03 (.98–1.07) .15
.0001 1.11 (.14–8.58) .91
.02 1 .10
.009 6.70 (.82–54.81) .07
.004 10.40 (1.20–89.77) .03
.02 5.26 (.57–48.05) .14
.29
.62
.93
.002 1.44 (.45–4.65) .53
.0001 2.35 (1.18–4.67) .01
5 tumor-node-metastasis.
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apy stratification and weighed together with other known
adverse factors to have more elements to consider an
aggressive oncologic therapy in perineural positive patients.
This study has some limitation mostly consisting in its
relatively small sample size, retrospective design, and
single-center conduction. Therefore, a large-scale prospec-
tive validation study is needed to confirm these results.
In summary, PNI is an independent marker of poor
prognosis in patients with gastric cancer. Identification of
sensitive markers for patients who had undergone curative
gastrectomy and who are at high risk of recurrence would
provide useful information for planning follow-up after
surgery or intensive adjuvant chemotherapy.References
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